Gainers

• QTREX Quantum (NASDAQ:QTEX) stock increased by 96.7% to $1.43 during Tuesday's pre-market session. The market value of their outstanding shares is at $31.6 million.
• Outlook Therapeutics (NASDAQ:OTLK) shares increased by 92.25% to $0.6. The market value of their outstanding shares is at $37.4 million.
• BiomX (AMEX:PHGE) stock rose 88.64% to $1.54. The company's market cap stands at $8.2 million. The company's, Q1 earnings came out 4 days ago.
• Artelo Biosciences (NASDAQ:ARTL) stock moved upwards by 52.1% to $1.81. The market value of their outstanding shares is at $2.7 million.
• Quantum BioPharma (NASDAQ:QNTM) shares increased by 19.04% to $11.0. The company's market cap stands at $59.1 million.
• Co-Diagnostics (NASDAQ:CODX) stock increased by 18.95% to $6.03. The company's market cap stands at $18.5 million.

Losers

• Aditxt (NASDAQ:ADTX) stock declined by 28.5% to $0.37 during Tuesday's pre-market session. As per the press release, Q1 earnings came out 4 days ago.
• Akari Therapeutics (NASDAQ:AKTX) shares declined by 24.75% to $13.75. The market value of their outstanding shares is at $20.9 million.
• rYojbaba (NASDAQ:RYOJ) shares fell 20.2% to $3.99. The company's market cap stands at $56.2 million.
• Akanda (NASDAQ:AKAN) shares fell 17.37% to $22.41. The market value of their outstanding shares is at $14.4 million.
• Editas Medicine (NASDAQ:EDIT) shares fell 16.67% to $2.3. The market value of their outstanding shares is at $270.2 million.
• CNS Pharmaceuticals (NASDAQ:CNSP) shares declined by 14.21% to $4.65. The company's market cap stands at $7.9 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.